Vivus Wins US Approval to Sell New Diet Drug Qsymia One of the ingredients in Qsymia (formerly known as Qnexa) is topiramate, which poses the risk of cleft lips in newborns of women taking the drug, according to the FDA and Vivus' own studies. Topiramate already is on the market to treat epileptic seizures ... 07/18/2012 - 1:29 am | View Link
Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ... 07/17/2012 - 12:32 pm | View Link
Vivus Wins FDA Approval MINYANVILLE ORIGINAL Vivus (VVUS) shareholders got a piece of good news late last week when the Food and Drug Administration approved the ... a decision on market clearance in April but the FDA delayed doing so until July 17. "The majority of the value ... 04/30/2012 - 9:07 am | View Link
Vivus' Erectile Dysfunction Drug Stendra Wins FDA Approval Law360, New York (April 27, 2012, 8:00 PM ET) -- The U.S. Food and Drug Administration on Friday approved Vivus Inc.'s erectile dysfunction pill Stendra, the first erectile dysfunction treatment to be allowed for use in the U.S. in a decade and the first ... 04/27/2012 - 1:00 pm | View Link
Vivus Obesity Pill Wins FDA Panel Nod; NeuroSearch Surges Competitor Orexigen Therapeutics Inc. also rose after the Food and Drug Administration advisers voted 20-2 yesterday that Qnexa’s benefits outweigh its risks. While the FDA isn’t required to follow the panel’s recommendation, it often does. 02/22/2012 - 11:00 am | View Link
FDA's Top Q4 Blockbuster Drug Decisions FierceBiotech is the drug development industry's news monitor, covering biopharma deals, clinical trials, FDA decisions, and more. Subscribe to our free ... 07/22/2014 - 4:03 pm | View Website
BioWorld | The Daily Biopharmaceutical News Source Contains business, science, and regulatory news, including mergers and collaborations, FDA hearings and results, and research breakthroughs. Need subscription to use. 07/22/2014 - 12:50 pm | View Website
VIVUS Inc VIVUS Inc, VVUS real time stock quotes, news, videos at CNBC.com 07/22/2014 - 5:19 am | View Website
VVUS Up to date analysis of Vivus, Inc. (VVUS) and its stock by hedge fund managers and industry experts. Find out what Vivus, Inc. is saying about its business from the ... 07/21/2014 - 6:27 pm | View Website
Is Arena or VIVUS the Better Obesity Drug Stock? (ARNA ... Arena and VIVUS have had a tough year. Is it finally time to take the contrarian view and consider them worthy investments? - Leo Sun - Health Care 05/31/2014 - 12:40 pm | View Website
Douglas Costa says he and his fellow players who are refusing to return to Ukrainian champion Shakhtar Donetsk do so because the conflict in the country puts their lives at risk. Costa and five other South American players refused to leave France last weekend with the rest of the team to return to Donetsk for Shakhtar's first match of the season on Tuesday.
Welcome to the new Atlantic Coast Conference. It's where a founding member is out, a fast-rising program is in, Notre Dame is there, too â?? sort of â?? and nobody else is leaving. Where a one-time punchline of a conference now boasts the Heisman Trophy winner, the reigning national champion and a handful of other individual award winners.
Tuesdays appeals court rulings on the Affordable Care Act dont change anything for North Carolina, said Sorien Schmidt, state director of Get Covered America, a national campaign to educate uninsured…